Supplementary_Table_1 - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals
Cameron M. Kieffer
Alexis Reisin Miller
Benjamin Chacko
Andrew S. Robertson
10.25384/SAGE.9970790.v1
https://sage.figshare.com/articles/journal_contribution/Supplementary_Table_1_-_FDA_Reported_Use_of_Patient_Experience_Data_in_2018_Drug_Approvals/9970790
<p>Supplemental Material, Supplementary_Table_1 for FDA Reported Use of Patient Experience Data in 2018 Drug Approvals by Cameron M. Kieffer, Alexis Reisin Miller, Benjamin Chacko and Andrew S. Robertson in Therapeutic Innovation & Regulatory Science</p>
2019-10-11 12:11:13
Patient Focused Drug Development
Regulatory Science
21st Century Cures Act
Drug Applications
Patient Reported Outcomes